2022
DOI: 10.1186/s12886-022-02478-9
|View full text |Cite
|
Sign up to set email alerts
|

Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema

Abstract: Background Patients with central retinal vein occlusion (CRVO) and macular edema often are treated by intravitreal ranibizumab injection (IRI). The role of changes in macular sensitivity in the positive effects of IRI on visual functions is unclear. Therefore, we assessed the relationship between macular sensitivity and improvement of visual functions. Methods We included 15 eyes of 15 patients with treatment-naïve CRVO and followed patients for 6 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Microperimetry was widely utilized in the field of central serous chorioretinopathy ( 5 ), central retinal vein occlusion ( 6 ), branch retinal vein occlusion ( 7 ), diabetic retinopathy ( 8 ), macular degeneration ( 9 ), etc.…”
Section: Introductionmentioning
confidence: 99%
“…Microperimetry was widely utilized in the field of central serous chorioretinopathy ( 5 ), central retinal vein occlusion ( 6 ), branch retinal vein occlusion ( 7 ), diabetic retinopathy ( 8 ), macular degeneration ( 9 ), etc.…”
Section: Introductionmentioning
confidence: 99%